Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTAVIA: Bevacizumab with Carboplatin and Weekly Paclitaxel in Ovarian Cancer
NCT00937560Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2009
- Primary completion
- Jul 2012
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of bevacizumab in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Roche. Started Jun 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00937560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937560.